Risk warning: Trading is risky. Your capital is at risk. Exinity Limited is regulated by FSC (Mauritius).
Risk warning: Trading is risky. Your capital is at risk. Exinity Limited is regulated by FSC (Mauritius).

FXTM Forex Market Update | 19/07/2018

Stock markets drifted lower as trade tensions weighed on market sentiment. The Dollar was king across currency markets thanks to US rate hike expectations. In the commodity arena, Oil depreciated while Gold tumbled to a fresh yearly low. The Pound weakened sharply after UK Retail sales heavily disappointed in June. - The #EURUSD remains pressured by monetary policy divergence - #GBPUSD has tumbled to a 10-month low - #Gold bears are eying $1200 For more Market Analysis read the latest @http://fxtm.co/marketupdate-fb

Recently Uploaded

Latest Market Research Articles

Pound ready to party?
Han Tan

3 July @ 06:40

By Han Tan, Market Analyst

Pound ready to party?
The Pound has seen a slight lift and is holding steady in the run up to the so-called ‘Super Saturday’ – as pubs, restaurants, and hotels reopen on July 4 after spending the past three months on lockdown. Sterling has been the third best performer among G10 currencies so far this month, gaining 0.... Read full post
Record jobs report, stocks on fire
Lukman Otunuga

2 July @ 18:50

By Lukman Otunuga, Research Analyst

Record jobs report, stocks on fire
Today was all about the US June non-farm payrolls report and it didn’t disappoint. After a catastrophic combined fall of 22 million jobs in March and April, last month saw a surprising rebound of 2.5 million. Today’s data continued that bounce, with the US economy adding 4.8 million jobs, a record... Read full post
Upbeat data and vaccine hopes keep the rally alive
Hussein Sayed

2 July @ 10:33

By Hussein Sayed, Chief Market Strategist (Gulf & MENA)

Upbeat data and vaccine hopes keep the rally alive
Stock markets across Asia tracked Wall Street higher today following upbeat data from the US and early positive results from Pfizer’s first phase of its Covid-19 vaccine trial. Investors seem to be focusing on the half full portion of the glass and not the other way round. That is evident in... Read full post
Scroll Top